1. Home
  2. ITRN vs ZYME Comparison

ITRN vs ZYME Comparison

Compare ITRN & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRN
  • ZYME
  • Stock Information
  • Founded
  • ITRN 1994
  • ZYME 2003
  • Country
  • ITRN Israel
  • ZYME United States
  • Employees
  • ITRN N/A
  • ZYME N/A
  • Industry
  • ITRN Electronic Components
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITRN Technology
  • ZYME Health Care
  • Exchange
  • ITRN Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • ITRN 810.3M
  • ZYME 968.5M
  • IPO Year
  • ITRN 2005
  • ZYME 2017
  • Fundamental
  • Price
  • ITRN $35.46
  • ZYME $15.84
  • Analyst Decision
  • ITRN Buy
  • ZYME Buy
  • Analyst Count
  • ITRN 1
  • ZYME 7
  • Target Price
  • ITRN $50.00
  • ZYME $20.00
  • AVG Volume (30 Days)
  • ITRN 174.4K
  • ZYME 461.7K
  • Earning Date
  • ITRN 08-19-2025
  • ZYME 10-30-2025
  • Dividend Yield
  • ITRN 5.63%
  • ZYME N/A
  • EPS Growth
  • ITRN 9.57
  • ZYME N/A
  • EPS
  • ITRN 2.79
  • ZYME N/A
  • Revenue
  • ITRN $339,610,000.00
  • ZYME $122,867,000.00
  • Revenue This Year
  • ITRN $7.03
  • ZYME $107.76
  • Revenue Next Year
  • ITRN $9.69
  • ZYME $2.35
  • P/E Ratio
  • ITRN $12.96
  • ZYME N/A
  • Revenue Growth
  • ITRN 3.30
  • ZYME 95.94
  • 52 Week Low
  • ITRN $25.87
  • ZYME $9.03
  • 52 Week High
  • ITRN $45.43
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • ITRN 46.17
  • ZYME 53.40
  • Support Level
  • ITRN $32.71
  • ZYME N/A
  • Resistance Level
  • ITRN $36.19
  • ZYME $16.37
  • Average True Range (ATR)
  • ITRN 1.22
  • ZYME 0.62
  • MACD
  • ITRN 0.25
  • ZYME -0.49
  • Stochastic Oscillator
  • ITRN 66.95
  • ZYME 96.76

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: